Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FNWAZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,639
Award facts
- Contract value 100% obligated
- $1,639.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,639.08 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order has a completion date of September 2, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Ondansetron is an anti-nausea medication commonly used in military and federal healthcare settings to manage chemotherapy-induced nausea and post-operative symptoms.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support for military healthcare programs, enabling the company to supply a diverse range of pharmaceutical products, medical supplies, and specialty medications to support Defense Health Agency operations and other federal healthcare systems worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement needs through its extensive portfolio of generic and brand-name medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FNWAZ?
SPE2DB25FNWAZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FNWAZ worth?
The government has obligated $1,639 on SPE2DB25FNWAZ.
Is contract SPE2DB25FNWAZ an order under another contract?
Yes. SPE2DB25FNWAZ is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNWAZ competed?
The extent of competition for SPE2DB25FNWAZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award